Innovative Science for Heart and Metabolic Health
At Pinewood Biotech Lab, we are actively engaged in the advancement of research targeting cardio-metabolic disorders—a growing global health crisis that includes conditions such as cardiovascular disease, type 2 diabetes, obesity, hypertension, and dyslipidemia.
Our approach combines molecular biology, genomics, and bioinformatics to understand the underlying mechanisms of metabolic dysregulation and cardiovascular dysfunction. Through this, we aim to develop targeted therapies, predictive biomarkers, and personalized treatment strategies that address the interconnected nature of these diseases.
Key Focus Areas:
• Biomarker Discovery for early detection and risk stratification
• Gene-environment Interaction Studies related to metabolic syndrome
• Targeted Therapeutics for insulin resistance, lipid metabolism, and vascular health
• Microbiome Research and its impact on metabolic pathways
• AI-Driven Data Analysis to model disease progression and therapeutic response
Our commitment to tackling cardio-metabolic disorders is driven by the vision of a future where early intervention, precision treatment, and prevention become the norm—not the exception.